de Winter D, Kaminski A, Tjoa M, Oepkes D, Lopriore E
BMC Pregnancy Childbirth. 2023; 23(1):738.
PMID: 37853331
PMC: 10583489.
DOI: 10.1186/s12884-023-06061-y.
Jajosky R, Patel K, Allen J, Zerra P, Chonat S, Ayona D
Blood. 2023; 142(12):1082-1098.
PMID: 37363865
PMC: 10541552.
DOI: 10.1182/blood.2022018591.
de Winter D, Kaminski A, Tjoa M, Oepkes D
BMC Pregnancy Childbirth. 2023; 23(1):12.
PMID: 36611144
PMC: 9824959.
DOI: 10.1186/s12884-022-05329-z.
Peahl A, Howell J
Am J Obstet Gynecol. 2020; 224(4):339-347.
PMID: 33316276
PMC: 9745905.
DOI: 10.1016/j.ajog.2020.12.016.
Hamel C, Esmaeilisaraji L, Thuku M, Michaud A, Sikora L, Fung-Kee-Fung K
PLoS One. 2020; 15(9):e0238844.
PMID: 32913362
PMC: 7482964.
DOI: 10.1371/journal.pone.0238844.
IgG Suppresses Antibody Responses to Sheep Red Blood Cells in Double Knock-Out Mice Lacking Complement Factor C3 and Activating Fcγ-Receptors.
Anania J, Westin A, Heyman B
Front Immunol. 2020; 11:1404.
PMID: 32733467
PMC: 7360818.
DOI: 10.3389/fimmu.2020.01404.
Hemolytic disease of the fetus and newborn due to Rh(D) incompatibility: A preventable disease that still produces significant morbidity and mortality in children.
Pegoraro V, Urbinati D, H A Visser G, Di Renzo G, Zipursky A, Stotler B
PLoS One. 2020; 15(7):e0235807.
PMID: 32687543
PMC: 7371205.
DOI: 10.1371/journal.pone.0235807.
Clinical value of different anti-D immunoglobulin strategies for preventing Rh hemolytic disease of the fetus and newborn: A network meta-analysis.
Xie X, Fu Q, Bao Z, Zhang Y, Zhou D
PLoS One. 2020; 15(3):e0230073.
PMID: 32163467
PMC: 7067404.
DOI: 10.1371/journal.pone.0230073.
Rh-incompatible hemolytic disease of the newborn in Hefei.
Bi S, Jiang L, Dai L, Zheng H, Zhang J, Wang L
World J Clin Cases. 2019; 7(20):3202-3207.
PMID: 31667170
PMC: 6819308.
DOI: 10.12998/wjcc.v7.i20.3202.
Antibody-mediated immunosuppression can result from RBC antigen loss independent of Fcγ receptors in mice.
Mener A, Patel S, Arthur C, Stowell S
Transfusion. 2018; 59(1):371-384.
PMID: 30474857
PMC: 7145427.
DOI: 10.1111/trf.14939.
Antibody-mediated immune suppression by antigen modulation is antigen-specific.
Maier C, Mener A, Patel S, Jajosky R, Bennett A, Arthur C
Blood Adv. 2018; 2(21):2986-3000.
PMID: 30413434
PMC: 6234375.
DOI: 10.1182/bloodadvances.2018018408.
The Ethics of Paid Plasma Donation: A Plea for Patient Centeredness.
Farrugia A, Penrod J, Bult J
HEC Forum. 2014; 27(4):417-29.
PMID: 25234254
DOI: 10.1007/s10730-014-9253-5.
Plasma-derived medicines: access and usage issues.
Farrugia A, Cassar J
Blood Transfus. 2012; 10(3):273-8.
PMID: 22244007
PMC: 3417725.
DOI: 10.2450/2011.0118-11.
The role of antenatal immunoprophylaxis in the prevention of maternal-foetal anti-Rh(D) alloimmunisation.
Liumbruno G, DAlessandro A, Rea F, Piccinini V, Catalano L, Calizzani G
Blood Transfus. 2010; 8(1):8-16.
PMID: 20104273
PMC: 2809506.
DOI: 10.2450/2009.0108-09.
The Rh protein family: gene evolution, membrane biology, and disease association.
Huang C, Ye M
Cell Mol Life Sci. 2009; 67(8):1203-18.
PMID: 19953292
PMC: 11115862.
DOI: 10.1007/s00018-009-0217-x.
Anti-D administration after childbirth for preventing Rhesus alloimmunisation.
Crowther C, Middleton P
Cochrane Database Syst Rev. 2000; (2):CD000021.
PMID: 10796089
PMC: 7061351.
DOI: 10.1002/14651858.CD000021.
Deaths from Rh haemolytic disease of the fetus and newborn, 1977-87.
Clarke C, Mollison P
J R Coll Physicians Lond. 1989; 23(3):181-4.
PMID: 2504914
PMC: 5387474.
Prevention of Rh-hemolytic disease.
Ladipo O
J Natl Med Assoc. 1977; 69(7):485-7.
PMID: 406416
PMC: 2536928.
